Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder

Middle East Current Psychiatry

Table 2 Severity and symptom dimension of schizophrenia, bipolar, and MDD among patient group

Patients with bipolar disorder		N	%
	Mild	0	0
YMRS	Moderate	38	76.00
	Severe	12	24.00
	Range	26–45
	Mean ± SD	33.200 ± 5.353
Patients with MDD		N	%
HAM-D	Mild	7	14.00
	Moderate	6	12.00
	Severe	20	40.00
	Very severe	17	34.00
	Range	10–38
	Mean ± SD	20.980 ± 5.985
Patients with schizophrenia
PANSS/P	Range	10–39
	Mean ± SD	22.240 ± 6.933
PANSS/N	Range	9–46
	Mean ± SD	23.300 ± 10.955
PANSS/G	Range	17–80
	Mean ± SD	31.980 ± 12.381

YMRS Young mania rating score, PANSS Positive and negative syndrome scale, PANSS/P Positive scale, PANSS/N negative scale, PANSS/G general scale. HAM-D Hamilton depression scale, SD Standard deviation